Literature DB >> 20388799

Tobacco and cancer: an American Association for Cancer Research policy statement.

Kasisomayajula Viswanath1, Roy S Herbst, Stephanie R Land, Scott J Leischow, Peter G Shields.   

Abstract

The evidence against tobacco use is clear, incontrovertible, and convincing; so is the need for urgent and immediate action to stem the global tide of tobacco-related death and suffering and to improve public health. The American Association for Cancer Research makes an unequivocal call to all who are concerned about public health to take the following immediate steps:Increase the investment in tobacco-related research, commensurate with the enormous toll that tobacco use takes on human health, to provide the scientific evidence to drive the development of effective policies and treatments necessary to dramatically reduce tobacco use and attendant disease. Develop new evidence-based strategies to more effectively prevent the initiation of tobacco use, especially for youth and young adults. Promote the further development of evidence-based treatments for tobacco cessation, including individualized therapies, and ensure coverage of and access to evidence-based behavioral and pharmacological treatments. Develop evidence-based strategies for more effective public communication to prevent, reduce, and eliminate tobacco use and to guide health policies and clinical practice. Develop effective, evidence-based policies to reduce disparities across the tobacco continuum among social groups and developed and developing nations. Implement to the fullest extent existing evidence-based, systems-wide tobacco control programs to prevent initiation and foster cessation. Adapt and implement appropriate approaches to reduce the growing burden of tobacco use in the developing world. Enhance and coordinate surveillance efforts, both in the United States and globally, to monitor tobacco products, tobacco use, and tobacco-related disease, including tobacco use in oncology clinical trials. Establish a comprehensive, science-based regulatory framework to evaluate tobacco products and manufacturers' claims. Promote research that addresses the following: the potential harms of current and new tobacco products; the impact of altering the levels of addictive components in tobacco products; the identification of risk and risk-reduction measures for current and former tobacco users; enhanced early detection methods for tobacco-related cancers; and effective treatments against tobacco-related cancers tailored to the unique effects of tobacco on cancer. Pursue domestic and international economic policies that support tobacco control. Urge the United States to ratify the World Health Organization Framework Convention on Tobacco Control. Foster global scientific efforts to support the Framework. Work together with stakeholders worldwide, including federal agencies, to develop and implement effective tobacco control strategies and to deter counter-tobacco control efforts by the tobacco industry. Only such concerted global actions by scientists, policymakers, and advocates together can prevent the invidious impact of tobacco, the use of which is cutting wide swathes of death and disease around the world. (c)2010 AACR.

Entities:  

Mesh:

Year:  2010        PMID: 20388799     DOI: 10.1158/0008-5472.CAN-10-1087

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

1.  Cigarette smoking, physical activity, and alcohol consumption as predictors of cancer incidence among women at high risk of breast cancer in the NSABP P-1 trial.

Authors:  Stephanie R Land; Qing Liu; D Lawrence Wickerham; Joseph P Costantino; Patricia A Ganz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-02-25       Impact factor: 4.254

2.  Environmental determinants of smoking behaviors: The role of policy and environmental interventions in preventing smoking initiation and supporting cessation.

Authors:  William A Calo; Sarah E Krasny
Journal:  Curr Cardiovasc Risk Rep       Date:  2013-12

3.  Monitoring of non-cigarette tobacco use using Google Trends.

Authors:  Patricia A Cavazos-Rehg; Melissa J Krauss; Edward L Spitznagel; Ashley Lowery; Richard A Grucza; Frank J Chaloupka; Laura Jean Bierut
Journal:  Tob Control       Date:  2014-02-05       Impact factor: 7.552

4.  Geographic Divergence in Mortality in the United States.

Authors:  Andrew Fenelon
Journal:  Popul Dev Rev       Date:  2013-12-01

5.  UGT2B gene expression analysis in multiple tobacco carcinogen-targeted tissues.

Authors:  Nathan R Jones; Philip Lazarus
Journal:  Drug Metab Dispos       Date:  2014-01-23       Impact factor: 3.922

6.  Induction of ovarian cancer and DNA adducts by Dibenzo[a,l]pyrene in the mouse.

Authors:  Kun-Ming Chen; Shang-Min Zhang; Cesar Aliaga; Yuan-Wan Sun; Timothy Cooper; Krishnegowda Gowdahalli; Junjia Zhu; Shantu Amin; Karam El-Bayoumy
Journal:  Chem Res Toxicol       Date:  2012-01-06       Impact factor: 3.739

7.  Tobacco assessment in actively accruing National Cancer Institute Cooperative Group Program Clinical Trials.

Authors:  Erica N Peters; Essie Torres; Benjamin A Toll; K Michael Cummings; Ellen R Gritz; Andrew Hyland; Roy S Herbst; James R Marshall; Graham W Warren
Journal:  J Clin Oncol       Date:  2012-06-11       Impact factor: 44.544

8.  Tobacco use in the oncology setting: advancing clinical practice and research.

Authors:  Ellen R Gritz; Benjamin A Toll; Graham W Warren
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-01       Impact factor: 4.254

9.  Smoking cessation is associated with lower rates of mood/anxiety and alcohol use disorders.

Authors:  P A Cavazos-Rehg; N Breslau; D Hatsukami; M J Krauss; E L Spitznagel; R A Grucza; P Salyer; S M Hartz; L J Bierut
Journal:  Psychol Med       Date:  2014-09       Impact factor: 7.723

10.  Automated tobacco assessment and cessation support for cancer patients.

Authors:  Graham W Warren; James R Marshall; K Michael Cummings; Michael A Zevon; Robert Reed; Pat Hysert; Martin C Mahoney; Andrew J Hyland; Chukwumere Nwogu; Todd Demmy; Elisabeth Dexter; Maureen Kelly; Richard J O'Connor; Teresa Houstin; Dana Jenkins; Pamela Germain; Anurag K Singh; Jennifer Epstein; Katharine A Dobson Amato; Mary E Reid
Journal:  Cancer       Date:  2013-10-25       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.